Home/Filings/4/0001209191-18-018014
4//SEC Filing

SULLIVAN JAMES M 4

Accession 0001209191-18-018014

CIK 0000917520other

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 4:23 PM ET

Size

9.3 KB

Accession

0001209191-18-018014

Insider Transaction Report

Form 4
Period: 2018-03-06
Transactions
  • Sale

    Common Stock

    2018-03-06$52.56/sh15,658$822,96159,604 total
  • Exercise/Conversion

    Common Stock

    2018-03-06$18.06/sh+15,658$282,78375,262 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2018-03-0615,6580 total
    Exercise: $18.06Exp: 2018-05-19Common Stock (15,658 underlying)
Footnotes (4)
  • [F1]The price shown above represents the weighted average price of the shares sold. The range of sale prices was $52.44 to $52.69.
  • [F2]25% of the stock options vest every quarter from the grant date of 5/19/2010
  • [F3]This option was previously reported as covering 7,500 shares at an exercise price of $41.75 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 7,829 shares of common stock at an exercise price of $36.12 per share.
  • [F4]In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.

Issuer

INTEGRA LIFESCIENCES HOLDINGS CORP

CIK 0000917520

Entity typeother

Related Parties

1
  • filerCIK 0001210128

Filing Metadata

Form type
4
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:23 PM ET
Size
9.3 KB